Market Tracker

05/23 4:36pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.5568
Delayed Data
As of 3:59pm ET
 -0.0032 / -0.57%
Today’s Change
0.28
Today|||52-Week Range
0.77
+80.54%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.56
Today’s open0.58
Day’s range0.54 - 0.58
Volume699,606
Average volume (3 months)2,991,661
Market cap$166.7M
Dividend yield--
Data as of 3:59pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+58.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+66.86%
P/E ratioNM
Price/Sales1.71
Price/Book2.65

Competitors

 Today’s
change
Today’s
% change
CURRCure Pharmaceutical ...-0.05-0.66%
RDHLRedhill Biopharma Lt...-0.20-1.94%
FOMXFoamix Pharmaceutica...+0.12+2.73%
IMDZImmune Design Corp-0.25-3.27%
Data as of 4:00pm ET, 05/23/2017

Financials

Next reporting dateJuly 17, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$44.7M
Annual profit (last year)-$55.7M
Net profit margin-124.54%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts